Every once in a while someone makes a statement that really resonates with you. At today’s luncheon, the topic was global health (of course!) and the challenges and opportunities for engaging in global health product development. Panelists included BIO’s Chairman of the Board, Joshua Boger, president and CEO of Vertex Pharmaceuticals; Una Ryan, CEO of AVANT Immunotherapeutics; Vijay Samant, president and CEO of Vical; and Henri Termeer, president and CEO of Genzyme Corporation.